Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

ViiV Healthcare

ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV. Shionogi joined in October 2012. The company’s aim is to take a deeper and broader interest in HIV/AIDS than any company has done before and take a new approach to deliver effective and new HIV medicines, as well as support communities affected by HIV. *

 

Period Start 2009-11-01 established jv
  Group GlaxoSmithKline (GSK) (Group)
Product Industry AIDS drug_o
Person Person Waterhouse, Deborah (ViiV Healthcare 201907 CEO)
     
Region Region Brentford, Greater London
  Country United Kingdom (GB)
  Street 980 Great West Road
  City TW8 9GS Brentford, Middlesex
  Tel +44-20-8380-6200
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: GlaxoSmithKline plc. (8/16/16). "Press Release: ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment".
     
   
Record changed: 2020-12-27

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for GlaxoSmithKline (GSK) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top